Vigil Neuroscience Inc (VIGL) Company Profile & Statistics

Vigil Neuroscience Inc
VIGL
(Nasdaq - US)
Closed
3.17
+0.17 (+5.67%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
Open
3.02
High
3.22
Low
3.02

About Vigil Neuroscience Inc

CEO

Ivana Magovcevic-Liebisch

Headquarters

100 forge road, suite 700

watertown, ma 02472, united states

Auditor

PricewaterhouseCoopers LLP

Employees

Share Holders

Website

www.vigilneuro.com

Industry

biotechnology

Sector

health technology

Company Overview

Vigil Neuroscience Inc. is a microglia-focused therapeutics company. It focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Vigil Neuroscience Inc. is based in CAMBRIDGE, Mass.

Vigil Neuroscience Inc Statistics

Valuation Measures

Market Capitalization ²	129.59M
Enterprise Value	84.69M
Enterprise Value/EBITDA (ttm)	-0.95
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.36
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-83.89%
Return on Invested Capital (ttm)	-84.93%
Return on Assets (ttm)	-65.34%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-88.91M
Net Income Avi to Common (ttm)	-82.60M
Diluted EPS (ttm)	-2.06

Share Statistics

Beta (5Y Monthly)	1.92
52-Week Change	-13.15%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	40.88M
Dividend Yield	0.00%
Float ⁴	27.38M
% Held by Insiders	33.03%
% Held by Institutions	83.64%

Balance Sheet

Total Cash (mrq)	111.27M
Total Cash Per Share (mrq)	2.72
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	3.72%
Quick Ratio (mrq)	3.72%
Book Value Per Share (mrq)	2.23

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.82
Free Cash Flow (ytd)	-33.09M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Vigil Neuroscience Inc

Trade With A Regulated Broker